Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD

NCT03803124 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Kidney, Autosomal Dominant

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Regional Hospital Holstebro